This is in line with previous observations from large cohorts of young patients with multiple sclerosis and healthy controls, where a larger distribution volume and specifically a larger total blood volume was postulated to be a modifier of blood NfL levels (Manouchehrinia et al., 2020). This evidence concerns the gene NEFL and multiple sclerosis.